Amgen (AMGN +0.1%) ups its 2013 EPS guidance to $7.05-7.35 from a prior forecast of $6.85 to...

|About: Amgen Inc. (AMGN)|By:, SA News Editor

Amgen (AMGN +0.1%) ups its 2013 EPS guidance to $7.05-7.35 from a prior forecast of $6.85 to $7.15 and vs consensus of $7.01, with the increase due to federal tax settlements for prior years. At a business review, Amgen reiterates revenues and capex guidance. Targets $1B in sales in new and emerging markets by 2015 as it looks to expand into key markets, including Japan and China. (PR)